Hadasit Bio Stock Net Income

HDST Stock   42.20  2.20  5.50%   
As of the 25th of February, Hadasit Bio retains the Market Risk Adjusted Performance of (0.56), downside deviation of 13.66, and Risk Adjusted Performance of 0.074. Hadasit Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hadasit Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hadasit Bio's valuation are provided below:
Hadasit Bio does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Search Suggestions

H Hyatt HotelsCompany
H HumanityCryptocurrency
HBANM Huntington Bancshares IncorporatedCompany
HIO Western Asset HighFund
HF DGA Core PlusETF
HGX PHLX HousingIndex
H3698DDS0 CS 6537 12 AUG 33Corporate Bond
HGUSD CopperCommodity
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Hadasit Bio reported net income of 28.36 M. This is 91.69% lower than that of the Biotechnology sector and 59.51% lower than that of the Health Care industry. The net income for all Israel stocks is 95.03% higher than that of the company.

Hadasit Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hadasit Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hadasit Bio could also be used in its relative valuation, which is a method of valuing Hadasit Bio by comparing valuation metrics of similar companies.
Hadasit Bio is currently under evaluation in net income category among its peers.

Hadasit Fundamentals

About Hadasit Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hadasit Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hadasit Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hadasit Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Hadasit Stock

Hadasit Bio financial ratios help investors to determine whether Hadasit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hadasit with respect to the benefits of owning Hadasit Bio security.